FibroGen Stock Drops By 34% In The Last 21 Sessions
FibroGen Inc, a biopharmaceutical firm, has experienced a sharp decline in its stock prices over a relatively short period. The company’s share prices have dropped by a significant 34.44% in just 21 trading sessions. This is a considerable contrast to the general trends on the NASDAQ, which has seen a general uptick of 0.61% over…